CARE vs INBK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

CARE

52.5
AI Score
VS
INBK Wins

INBK

60.1
AI Score

Investment Advisor Scores

CARE

53score
Recommendation
HOLD

INBK

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE INBK Winner
Forward P/E 13.6612 8.4459 INBK
PEG Ratio 0 0 Tie
Revenue Growth 68.3% 39.0% CARE
Earnings Growth 253.9% 1250.1% INBK
Tradestie Score 52.5/100 60.1/100 INBK
Profit Margin 44.9% -57.0% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: -2.7% · 3M: -7.4% INBK 1M: -3.0% · 3M: -1.1%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $30.75

INBK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.4 · Price: $27.62

Fundamentals Snapshot

Metric CARE INBK
Market Cap — —
Forward P/E 11.8 6.1
Trailing P/E 5.2 —
Revenue (TTM) — —
Revenue Growth 0.7% 0.4%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.1%
EPS 5.89 -3.71
Dividend Yield 0.00% 0.01%

Frequently Asked Questions

Based on our detailed analysis, INBK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.